drugset

drugset / Trial / NCT00165737

Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease

NCT00165737 ↗

Phase 3 Completed 974 enrolled Eisai Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

Twenty-four week, prospective, randomized, double-blind, placebo-controlled, parallel-group study.

Timeline

Start: 2003-03
Primary completion: 2005-08
Completion: 2006-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Donepezil	Small molecule	—	—

Indications